Plain-English translation of NCT07196462 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a treatment called repetitive transcranial magnetic stimulation (rTMS)—a non-invasive procedure that uses magnetic pulses to stimulate specific brain regions—can help reduce cannabis cravings in people with schizophrenia. Researchers believe that cannabis use in schizophrenia may be linked to imbalances in brain networks, and that this treatment might help correct those imbalances and reduce the urge to use cannabis.
Right now, there are no approved treatments to help people with schizophrenia stop using cannabis, even though cannabis use is very common in this population and makes schizophrenia symptoms much worse. This trial exists to test whether the new brain stimulation approach could fill that gap and help patients break free from cannabis dependence.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive rTMS—a procedure where a magnetic coil is placed on your scalp to stimulate brain activity in a specific area. This is painless and non-invasive. You will also be compared to healthy volunteers who use cannabis to help researchers understand how the treatment works differently in people with schizophrenia. The study involves regular visits where researchers will assess your cannabis cravings, symptoms, and how well the treatment is working.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
United States